COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S - Share repurchase programme

03/12/2018 - 14:26

Bagsværd, Denmark, 3 December 2018 - On 5 November 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

XBiotech Announces Successful Completion of GMP Audit

03/12/2018 - 14:15

First Audit in Company’s New Manufacturing Facility Shows Compliance with GMP Guidelines AUSTIN, Texas, Dec. 03, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) today announced a successful GMP (Good Manufacturing [...]

Data Presented at AACR Special Conference on PI3K/mTOR Signaling Demonstrates Potential of eFFECTOR’s eIF4E Inhibitors in Cancer

03/12/2018 - 14:10

SAN DIEGO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., (eFFECTOR), a leader in the development of selective translation regulators (STRs) for the treatment of cancer, announced today that it presented [...]

Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2019 After Market Close on December 10, 2018

03/12/2018 - 14:05

TUSTIN, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract development and manufacturing organization (CDMO) working to improve patient lives by providing [...]

Catalyst Pharmaceuticals Announces Conference Call to Discuss Commercialization Plan for Firdapse® (amifampridine) for Lambert-Eaton Myasthenic Syndrome (LEMS)

03/12/2018 - 14:03

U.S. launch scheduled for early in the first quarter of 2019 Catalyst is well-capitalized and sees no current need for capital infusion CORAL GABLES, Fla., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc [...]

Nuvectra Receives FDA Head-Only MR-Conditional Approval for Algovita®

03/12/2018 - 14:01

PLANO, Texas, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has received U.S. Food and Drug Administration (FDA) head-only MR- [...]

Selecta Biosciences Announces New Employment Inducement Grants

03/12/2018 - 14:00

WATERTOWN, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]

GBT Announces U.S. FDA Agrees with its Proposal Relating to Accelerated Approval Pathway for Voxelotor for the Treatment of Sickle Cell Disease and GBT Plans to Submit New Drug Application (NDA)

03/12/2018 - 14:00

Pre-NDA Meeting to be Requested for First Quarter of 2019 Company to Host Conference Call and Webcast Today, Monday, December 3, at 5:30 a.m. PT/8:30 a.m. ET SOUTH SAN FRANCISCO, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE [...]

Aduro Biotech and Dana-Farber Cancer Institute Present Preclinical Data Supporting Anti-APRIL Antibody BION-1301 for the Treatment of Multiple Myeloma at the 60th American Society of Hematology Annual Meeting and Exposition

03/12/2018 - 14:00

BERKELEY, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced preclinical data in two abstracts for its first-in-class anti-APRIL antibody BION-1301 supporting its potential use [...]

Rexahn Pharmaceuticals Appoints Gil Price to its Board of Directors

03/12/2018 - 14:00

ROCKVILLE, Md., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to improve patient outcomes in cancers that [...]

Study of Feraheme demonstrates Improvements in Fatigue and Quality Of Life in Iron Deficiency Anemia Patients

03/12/2018 - 14:00

Key Findings of a 6-Month Extension Study Presented at the American Society of Hematology Annual Meeting WALTHAM, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that [...]

Tabula Rasa HealthCare to Acquire DoseMe, a Precision Dosing Software Company

03/12/2018 - 14:00

Acquisition projected to expand reach of TRHC’s medication safety technologies in the hospital healthcare system market and internationally MOORESTOWN, N.J., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc [...]

Gemphire Therapeutics Announces Review of Strategic Alternatives and Provides Corporate Update

03/12/2018 - 14:00

LIVONIA, Mich., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, [...]

LogicBio Reports Third Quarter 2018 Financial Results

03/12/2018 - 14:00

CAMBRIDGE, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC) (LogicBio or the Company), a genome editing company focused on developing medicines to durably treat rare diseases in [...]

Tetra Natural Health Will Deliver 20 containers of Hemp Energy Drink to Meet Consumer Demand

03/12/2018 - 14:00

ORLEANS, Ontario, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Tetra Natural Heath, a subsidiary of Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), announces the delivery of twenty containers, more than 1.7 million cans of its [...]

Tetra Santé Naturelle livrera 20 conteneurs de Hemp Energy Drink pour répondre à la demande

03/12/2018 - 14:00

ORLEANS, Ontario, 03 déc. 2018 (GLOBE NEWSWIRE) -- Tetra Santé Naturelle, une filiale de Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), annonce la livraison de vingt (20) conteneurs, soit plus de 1,7 millions de [...]

Quotient Limited Announces Initial MosaiQ™ SDS Verification and Validation Data

03/12/2018 - 14:00

JERSEY, Channel Islands, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported positive Verification and Validation (V&V) concordance [...]

Nephros to Present at the 11th Annual LD Micro Main Event

03/12/2018 - 13:30

Presentation Scheduled for 9:30 AM PT on Tuesday, December 4th SOUTH ORANGE, NJ, Dec. 03, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Nephros, Inc. (OTCQB: NEPH) (“Nephros”), a commercial stage medical device company [...]

Onconova Highlights Results from Phase 2 Trial of Oral Rigosertib In Combination with Azacitidine (Vidaza®) in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting

03/12/2018 - 13:30

Overall response rate (ORR) of 90% reported in this multi-institutional Phase 2 study in hypomethylating agent (HMA) naïve patients, including Complete Remission (CR) rate of 34% ORR of 54% and CR/Partial Response (PR) [...]